Sanofi announced on Oct. 12, 2017 that it is investing EUR 170 million (US$201 million) to expand a vaccine manufacturing site in Val de Reuil, France, which will include a new facility. The new facility will allow Sanofi Pasteur, Sanofi s global vaccines business unit, to expand supply of VaxigOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.